Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Enbrel
Enbrel
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
AbbVie
Amgen
biosimilars
JNJ
Sandoz
Novartis
Humira
Neupogen
Remicade
Nuelasta
Enbrel
epoetin-alfa
Pfizer Products with Negative 2Q15 Growth
Yahoo/Market Realist
Fri, 08/14/15 - 09:49 am
Pfizer
Lyrica
Enbrel
Celebrex
Lipitor
Zyvox
The Top Drug Launches Of All Time
Forbes
Wed, 08/5/15 - 08:04 am
Sovaldi
Lipitor
Humira
Plavix
Advair
Remicade
Enbrel
Prilosec
Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA
BioPharma Dive
Wed, 06/10/15 - 11:10 am
Merck
Remicade
Enbrel
biosimilars
rheumatoid arthritis
Amgen Indulges in Another Rheumatoid Arthritis Drug Price Increase
TheStreet.com
Tue, 05/5/15 - 05:52 pm
Amgen
drug pricing
rheumatoid arthritis
Enbrel
Biogen Goes Generic
Investopedia
Fri, 04/10/15 - 10:12 am
Biogen
generics
Rituxan
anti-TNF
SB4
biosimilars
Remicade
SB2
Enbrel
What Products Affect Pfizer’s Revenue?
Yahoo/Market Realist
Tue, 03/31/15 - 07:51 am
Pfizer
Lyrica
Prevnar
Enbrel
Celebrex
Lipitor
Viagra
Zyvox
Sutent
Norvasc
Premarin
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Fri, 11/21/14 - 10:30 am
Novartis
Enbrel
psoriasis
Cosentyx
The 10 best-selling drugs of 2013
Fierce Pharma
Tue, 03/25/14 - 10:07 am
Seretide
Rituxan
Remicade
MabThera
Lantus
Humira
Herceptin
Enbrel
Crestor
Avastin
Advair
Abilify
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Fierce Biotech
Tue, 09/3/13 - 11:19 am
Coherus Biosciences
Baxter International
Enbrel
biosimilars
Amgen
The 5 Best-Selling Medications of 2013 (So Far)
Motley Fool
Tue, 08/6/13 - 11:24 am
AbbVie
Humira
Advair
GSK
Seretide
Enbrel
Amgen
Pfizer
Lantus
Sanofi
Avastin
Roche
Novartis' psoriasis drug superior to Enbrel in study
Reuters
Mon, 07/8/13 - 10:39 am
Novartis
psoriasis
Enbrel
secukinumab
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Mon, 06/24/13 - 10:44 am
Amgen
Enbrel
generics
Sandoz
Novartis
chronic plaque psoriasis
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »